SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-011370
Filing Date
2023-03-31
Accepted
2023-03-31 16:06:07
Documents
7
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre_14a-2023_proxy_preli.htm PRE 14A 1033511
2 GRAPHIC img88483450_0.jpg GRAPHIC 9568
3 GRAPHIC img88483450_1.jpg GRAPHIC 647786
4 GRAPHIC img88483450_2.jpg GRAPHIC 87936
5 GRAPHIC img88483450_3.jpg GRAPHIC 9568
6 GRAPHIC img88483450_4.jpg GRAPHIC 140936
7 GRAPHIC img88483450_5.jpg GRAPHIC 186789
  Complete submission text file 0000950170-23-011370.txt   2514609
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39094 | Film No.: 23787573
SIC: 2834 Pharmaceutical Preparations